The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
“As the complaint explains, the PBMs have created and manage a system in which drug manufacturers compete for formulary ...
The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit ...
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of tamping down prescription drug costs. The new law targets pharmacy benefit ...
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.
The complaint targets the group purchasing organizations affiliated with the "big three" pharmacy benefit managers: CVS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback